AAG
ORTX

Armstrong Advisory Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Armstrong Advisory Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$27 – 829
2023
Q1 		$27 Hold
5
– – ﹤0.01% 782
2022
Q4 		$19 Buy
+5
New +$22 ﹤0.01% 810

Other funds holding ORTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armstrong Advisory Group's ORTX Position: Q2 2023 in Review

Armstrong Advisory Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2023, closing a stake of 5 shares — an estimated $27 sold.

Armstrong Advisory Group first reported a position in ORTX in Q4 2022 and held it in 2 quarters. The position peaked at $27 in Q1 2023. 33 funds tracked by Wall St. Rank hold ORTX as of Q2 2023.

  • Armstrong Advisory Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Armstrong Advisory Group sold 5 Orchard Therapeutics plc American Depositary Shares shares in Q2 2023, an estimated $27.
  • Armstrong Advisory Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2022 and held it in 2 quarters.
  • Armstrong Advisory Group's Orchard Therapeutics plc American Depositary Shares position peaked at $27 in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2023.

Based on Armstrong Advisory Group's 13F filing for Q2 2023, filed 6 Jul 2023.